- Home
- ITRM vs HERZ Comparison
ITRM vs HERZ Comparison
Compare ITRM & HERZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ITRM | HERZ |
|---|---|---|
| Founded | 2015 | N/A |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 28.3M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ITRM | HERZ |
|---|---|---|
| Price | $0.24 | $15.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 612.9K | 39.5K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.43 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $947.65 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $1.62 |
| 52 Week High | $1.49 | $19.30 |
Technical Indicators
Market Signals| Indicator | ITRM | HERZ |
|---|---|---|
| Relative Strength Index (RSI) | 38.23 | 71.18 |
| Support Level | N/A | $2.16 |
| Resistance Level | $0.39 | $19.30 |
| Average True Range (ATR) | 0.03 | 0.76 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 32.07 | 75.60 |
Price Performance
Historical ComparisonAbout ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About HERZ Herzfeld Credit Income Fund Inc.
Herzfeld Credit Income Fund Inc is a non-diversified, closed-end management investment company. Its primary investment objective is to maximize risk-adjusted total returns, and its secondary investment objective is to generate high current income.